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Abstract
Background: Porcine epidemic diarrhea virus (PEDV) is a highly contagious enteric pathogen of swine. The spike
glycoprotein (S) of PEDV is the major immunogenic determinant that plays a pivotal role in the induction of
neutralizing antibodies against PEDV, which therefore is an ideal target for the development of subunit vaccine. In an
attempt to develop a subunit vaccine for PEDV, we cloned two different fragments of S protein and expressed
as glutathione S-transferase (GST)-tagged fusion proteins, namely rGST-COE and rGST-S1D, in E.coli. However, the
expression of these recombinant protein antigens using a variety of expression vectors, strains, and induction
conditions invariably resulted in inclusion bodies. To achieve the soluble expression of recombinant proteins,
several chaperone co-expression systems were tested in this study.
Results: We firstly tested various chaperone co-expression systems and found that co-expression of trigger factor
(TF) with recombinant proteins at 15 °C was most useful in soluble production of rGST-COE and rGST-S1D
compared to GroEL-ES and DnaK-DnaJ-GrpE/GroEL-ES systems. The soluble rGST-COE and rGST-S1D were
purified using glutathione Sepharose 4B with a yield of 7.5 mg/l and 5 mg/l, respectively. Purified proteins
were detected by western blot using mouse anti-GST mAb and pig anti-PEDV immune sera. In an indirect
ELISA, purified proteins showed immune reactivity with pig anti-PEDV immune sera. Finally, immunization of
mice with 10 μg of purified proteins elicited highly potent serum IgG and serum neutralizing antibody titers.
Conclusions: In this study, soluble production of recombinant spike protein of PEDV, rGST-COE and rGST-S1D,
were achieved by using TF chaperone co-expression system. Our results suggest that soluble rGST-COE and
rGST-S1D produced by co-expressing chaperones may have the potential to be used as subunit vaccine antigens.
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Background
Porcine epidemic diarrhea (PED) is a highly infectious
and contagious enteric disease of swine [1]. The disease
is characterized by severe diarrhea, vomiting, dehydra-
tion and death, with a high mortality rate of more than
90 % in suckling piglets [2]. In the early 1970s, the first
case of PED was reported in England [3]. Since then, the
disease has spread to Europe and most of the Asian
swine raising countries, and severely affected swine in-
dustry in Asia [4, 5]. In 2013, PED suddenly occurred in
the United States and rapidly spread across the country
[6], as well as neighboring countries [7, 8], and subse-
quently in Asian countries including South Korea [9],
Japan and Taiwan [10], and led to significant economic
losses in the global swine industry [11]. Thus, it is
important to develop an effective vaccine for the preven-
tion of PED.
A coronavirus named porcine epidemic diarrhea virus
(PEDV) was identified as the causative agent of PED in
the late 1970s [2]. The virus possesses four structural
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proteins including 150–220 kDa spike (S) glycoprotein,
7 kDa envelop (E) protein, 20–30 kDa membrane (M)
protein and 58 kDa neucleocapsid (N) protein [12]. The
S protein is a transmembrane glycoprotein localized on
the virion surface, which can be divided into the S1 (aa
1–789) domain and S2 (aa 790–1383) domain [13, 14].
The S protein plays a pivotal role in the cellular receptor
binding, viral fusion, and most importantly in the induc-
tion of neutralizing antibodies [15, 16]. A neutralizing
epitope region, COE (aa 499–638), corresponds to the
neutralizing epitope of transmissible gastroenteritis virus
(TGEV), was identified based on the nucleotide sequence
homology analysis [17]. Subsequently, a novel neutralizing
epitope region S1D (aa 636–789) on the S1 domain was
reported to have the capacity to induce neutralizing anti-
bodies against PEDV [13]. In addition, a B-cell epitope
2C10 (aa 1,368–1,374) on the S2 domain was also re-
ported to induce neutralizing antibodies [18]. Therefore,
spike protein is considered as a primary target for the
development of subunit vaccine against PEDV.
Up to the present, a number of expression systems
have been used to produce S protein of PEDV, such as
mammalian cells [16], transgenic plant [19], yeast [20]
and E.coli [13, 17]. Despite absence of post-translational
modifications (such as phosphorylation, acetylation, and
glycosylation), expression of recombinant proteins in E.
coli has many significant benefits over other expression
systems in terms of cost, ease-of-use, and scale [21].
However, recombinant protein overexpression in E.coli
often leads to the misfolding of the protein of interest
into biologically inactive aggregates known as inclusion
bodies (IBs) [22]. Various expression approaches have
been suggested to prevent IBs formation, including
utilization of solubility enhancing tag, lowering induc-
tion temperature, modulating inducer concentration and
changing specialized expression hosts [23]. Moreover,
many refolding methods have also been explored for the
recovery of soluble proteins from purified IBs [24, 25].
However, these approaches are not always effective, since
even the most robust protocols only refold a small
fraction of the input protein, and it is difficult to purify
the refolded fraction [26]. As an alternative strategy,
chaperone co-expression strategies have been proposed
to facilitate soluble expression of recombinant proteins
with success for many different types of proteins [27–29].
Chaperones are complex molecular machinery that as-
sists the folding of newly synthesized proteins to the
native state and provide a quality control system that
refolds misfolded and aggregated proteins [30, 31]. In
the E.coli cytosol, a ribosome-associated folding catalyst
known as trigger factor and molecular chaperone teams
such as the DanK-DnaJ-GrpE and the GroEL-GroES
are profoundly involved in the folding and refolding
process [32–35].
In the present study, we report the results of the
chaperone-assisted production of soluble rGST-COE
and rGST-S1D in E.coli as well as the evaluation of
immunogenicity and efficacy of purified recombinant
proteins as a subunit vaccine antigen.
Results and discussion
Chaperone assisted expression of soluble rGST-COE and
rGST-S1D
Based on the sequence information of the spike protein
of PEDV CV777 strain, we constructed pG-COE and
pG-S1D expression plasmids, producing rGST-COE
(containing 138 amino acids spanning the region of
499–636 amino acids) [17] and rGST-S1D (containing
153 amino acids spanning the region of 637–789 amino
acids) [13], respectively. However, unlike the previous
reports [13, 17], our initial attempts to produce rGST-
COE and rGST-COE using a pGEX 6p-1 vector system
with various induction conditions resulted in IBs (data
not shown). Since, both of the COE and S1D regions
contain 4 cysteine residues in the protein sequence, we
also performed expression of these clones in E.coli
Rosetta-gami™2 (DE3) (Novagen, Darmstadt, Germany)
strain known to enhance disulfide bond formation in the
cytoplasm, although the yield of soluble proteins was
negligible (data not shown).
Previously, chaperone co-expression system has been
reported to improve the solubility of various aggregation-
prone recombinant proteins, such as human interferon-
gamma, mouse endostatin, human ORP150 and human
lysozyme [27, 36]. Therefore, we decided to test the effect
of chaperone systems, such as trigger factor (TF), GroEL-
ES, DnaKJE/GroEL-ES and GroEL-ES/TF, on the produc-
tion of soluble rGST-COE and rGST-S1D. The pG-COE
and pG-S1D expression plasmids were transformed in to
the E.coli BL21, BL21/pTF16, BL21/pGro7, BL21/pG-
KJE8 and BL21/pG-Tf2 chaperone competent cells. As
shown in Fig. 1, we found that co-expression of TF with
recombinant proteins at 15 °C was most useful in soluble
production of rGST-COE and rGST-S1D compared to
other chaperone combinations (Fig. 1). Majority of the
recombinant proteins were presented in insoluble fraction
when expressed alone, while co-expression of recombin-
ant proteins with TF resulted in up to 84 % soluble frac-
tion for the rGST-COE, and 41 % for the rGST-S1D
compared to 19 ~ 30 % of other chaperone systems. Total
amount of recombinant proteins expressed were de-
creased to 40 ~ 50 % value of no chaperone induction.
Interestingly, TF system is a cold shock chaperone, while
the GroEL-ES and the DnaK-DnaJ-GrpE systems belong
to the heat shock chaperones and the ratios of chaperone
combinations are critical in the folding or refolding
process [30, 37]. In this study as we used commercial
system, the ratios of chaperones or other conditions were
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not optimized for the PEDV antigen expression. Nonethe-
less, TF system is simple and most effective among the
tested conditions for the soluble expression of PEDV anti-
gens and do not require co-chaperones or ATP as com-
pared to the GroEL-ES and the DnaK-DnaJ-GrpE systems.
Furthermore, TF, a ribosome associated chaperone, is
the first chaperone that interacts with nascent polypep-
tide chains and assists co-translational protein folding
[38]. Thus, TF may be essential for the correct folding
of rGST-COE and rGST-S1D during initial de novo
folding steps [27, 39]. It was reported that formation of
GroEL/TF complex can further enhance binding affinity
of GroEL to unfolded protein and facilitate protein
folding or denaturation. However, co-expression of
GroES-GroEL/TF system (E.coli BL21/pG-Tf2) was not
successful in our case due to the growth inhibition ob-
served upon chaperone induction (data not shown).
As shown in Fig. 2, SDS–PAGE revealed the expres-
sion of TF (56 kDa) induced by L-arabinose and the ex-
pression of rGST-COE (Fig. 2a) and rGST-S1D (Fig. 2b)
induced by IPTG. Recombinant proteins or chaperone
TF was not produced without IPTG or L-arabinose in-
duction, respectively. Insoluble recombinant proteins
were produced with IPTG in the absence of L-arabinose.
Soluble recombinant proteins were produced only in the
presence of TF. As a result, it was confirmed that co-
expression of TF highly improved the solubility of rGST-
COE and rGST-S1D.
Optimization of expression conditions for soluble
rGST-COE and rGST-S1D production
To maximize the soluble expression of rGST-COE and
rGST-S1D, expression conditions for E.coli BL21/pTf16/
pG-COE and E.coli BL21/pTf16/pG-S1D were optimized
Fig. 1 Chaperone assisted expression of soluble rGST-COE (a) and rGST-S1D (b). Chaperone proteins were induced at 37 °C by adding L-arabinose
(0.5 mg/ml) or tetracycline (10 ng/ml) prior to the expression of recombinant proteins. Target proteins were induced by adding 0.1 mM IPTG at 15 °C
for 24 h. Soluble (S) and insoluble (I) fractions were analyzed by SDS-PAGE. The protein bands for rGST-COE, rGST-S1D and chaperone proteins are
indicated on the right side of the gel. Lanes: control, no chaperone; +TF, co-expression with trigger factor; +Gro, co-expression with GroEL-GroES
complex; +G-KJE: co-expression with DnaKJE/GroEL-GroES complex
Fig. 2 Effect of trigger factor (TF) on the solubility of rGST-COE (a) and rGST-S1D (b). TF was induced prior to the expression of recombinant proteins
by adding L-arabinose (0.5 mg/ml) at 37 °C. Target proteins were induced by adding 0.1 mM IPTG at 15 °C for 24 h. Soluble (S) and insoluble
(I) fractions were analyzed by SDS-PAGE. The protein bands for rGST-COE, rGST-S1D and TF are indicated. Lanes: −/−, no induction; A/-, induction with
L-arabinose; −/I, induction with IPTG; A/I, induction with L-arabinose and IPTG
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by regulating induction temperature, IPTG concentra-
tion, OD at induction and harvest time. The rate of ex-
pression and culture temperature can affect the proper
folding and IBs formation of most recombinant proteins
[40–42]. In order to determine the optimal induction
temperature, rGST-COE was induced at different tem-
peratures (15, 21, 28 and 37 °C), while TF was induced
with L-arabinose from the culture start. SDS-PAGE
results showed that optimal temperature for soluble
rGST-COE expression was 15 °C, as the solubility of
rGST-COE was increased progressively as temperature de-
creased from 37 °C to 15 °C. (Additional file 1: Figure S1).
Interestingly, the expression level of TF was also increased
as the temperature decreased. Indeed, it has been reported
that TF, unlike other chaperones in E.coli, is a cold-shock
chaperone which was induced at low temperature [37].
Our data suggest that the improved solubility of rGST-
COE at low temperature may be attributed to the elevated
expression level of TF, but not duo to the reduction of
expression rate at low temperature.
After determining the optimal expression temperature,
the effect of IPTG concentration (0.1, 0.4, 0.7 and 1.0 mM),
OD at induction (at OD600 0.6, 0.9, 1.2 and 1.5) and
harvest time (12, 24, 36 and 48 h after induction) were
examined on the efficiency of soluble expression. Optimal
conditions for soluble expression were 0.1 mM IPTG
concentration, induction start at OD600 0.6, and induction
time of 24 h or 12 h for rGST-COE and rGST-S1D
at 15 °C (Fig. 3).
Purification and western blot confirmation of rGST-COE
and rGST-S1D
The soluble rGST-COE and rGST-S1D fractions were
purified by affinity column chromatography using gluta-
thione Sepharose 4B. The soluble fraction obtained after
cell lysis and centrifugation was loaded on the column
pre-equilibrated with buffer A (140 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4 at
pH 7.3). The column was washed successively with buf-
fer A. The bound proteins were eluted using buffer B
(50 mM Tris–HCl and 10 mM glutathione at pH 8.0)
and fractions containing purified proteins were collected
and the purity of the protein was analyzed by SDS-
PAGE (Additional file 1: Figure S2). When determined
by Bradford assay, the yield of purified soluble rGST-
COE and rGST-S1D in flask culture were 7.5 mg/l and
Fig. 3 Optimization of IPTG concentration (a), OD at induction (b) and harvest time (c) for soluble rGST-COE and rGST-S1D expression. The amount of
soluble (S) and insoluble (I) fractions were compared relatively with each starting condition (IPTG = 0.1 mM, OD= 0.6, Time = 12 h), respectively, according
to the band intensities of SDS-PAGE. The experiment was conducted twice independently, and the data from a representative experiment are shown
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5 mg/l, respectively. The purity of the pooled fractions
was >90 % and we used them without further purifica-
tion. 1 μg of purified proteins were separated in the
SDS-PAGE (Additional file 1: Figure S3), and target pro-
teins were detected using mouse anti-GST monoclonal
antibody and pig anti-sera against commercial PEDV live
attenuated vaccine in a western blot analysis (Fig. 4).
The rGST protein was included as a control for the
western blot analysis. No clear bands were detected with
pre-immune sera used as a control in western blot (data
not shown). Pig anti-PEDV immune sera showed weak
signal, high background and some non-specific reactivity
in western blot (Fig. 4b) compared to the ELISA result
(Fig. 6). It seems that those two results are not matching
to some extent. But, it may be possible to get those re-
sults, because the pig anti-PEDV sera was raised against
live attenuated virus, which contained polyclonal anti-
bodies recognizing both conformational and linear epi-
topes on the native PEDV spike protein. Therefore, the
pig anti-PEDV sera could detect both conformational
and linear epitopes on rGST-COE and rGST-S1D in an
ELISA assay, while pig anti-PEDV sera could react only
with linear epitopes on denatured rGST-COE and rGST-
S1D in a western blot. In this context, it is possible
that the reaction in ELISA was much stronger than
in western blot.
Neutralization antibody response of rGST-COE and rGST-S1D
To determine the immunogenicity of rGST-COE and
rGST-S1D, mice were immunized subcutaneously with
10 μg of purified proteins for 3 times at 2-weeks inter-
vals. Mouse anti-sera were collected before and at 14,
28, 42 days after immunization. The 96 well plates were
coated with purified rGST-COE or rGST-S1D and
reacted with corresponding mouse anti-sera diluted at
1:200 ~ 1:25600 for the detection of antigen specific serum
IgG levels. Both rGST-COE and rGST-S1D strongly elic-
ited antigen specific serum IgG production after third
injection of antigens (Fig. 5). In the indirect ELISA, rGST-
COE and rGST-S1D also showed significant reactions
with pig anti-PEDV immune sera (Fig. 6).
To test whether immunization of mice with rGST-COE
and rGST-S1D could elicit specific neutralizing antibodies
against PEDV, terminal serum samples collected from im-
munized mice were subjected to the serum neutralization
assay. As shown in Fig. 7, immunization of mice with
rGST-COE and rGST-S1D showed significantly higher SN
titer than control mice received PBS.
Even though Sun et al. [13] argued only S1D being ef-
fective for the induction of neutralizing antibodies, we
confirmed through this study the previous report which
showed COE and S1D fragments of PEDV spike protein
working as neutralizing epitopes [17]. However, unlike
the reports of soluble expression of theses antigens
[13, 17], the expression of these recombinant antigens
using a variety of expression vectors, strains, and induc-
tion conditions invariably resulted in inclusion bodies
without proper chaperone co-expression such as TF.
Even though we exactly matched the reports in terms
of vector, amino acid sequence including GST fusion,
E.coli strain, and optimization of induction conditions,
we could not reproduce the soluble production without
the chaperone support.
Conclusions
In this study, two recombinant fragments of PEDV spike
protein, COE and S1D, were produced in soluble forms
using a chaperone, TF co-expression system in E.coli.
Fig. 4 Detection of purified rGST-COE and rGST-S1D proteins by western blot analysis using mouse anti-GST monoclonal antibody (a) and pig
anti-PEDV immune sera (b). Lanes: 1, rGST-COE; 2, rGST-S1D; 3, rGST (Control)
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Without TF, these antigens invariably resulted in inclu-
sion bodies in variety of expression vectors, host strains,
and induction conditions tested. Co-expression of TF
with recombinant proteins at 15 °C was most useful in
soluble production of rGST-COE and rGST-S1D com-
pared to GroEL-ES and DnaK-DnaJ-GrpE/GroEL-ES
systems. The soluble rGST-COE and rGST-S1D were
purified and detected by western blot using mouse anti-
GST mAb and pig anti-PEDV immune sera, and showed
dominant immune reactivity with pig anti-PEDV immune
sera in an indirect ELISA assay. Finally, immunization of
mice with 10 μg of purified proteins elicited highly potent
serum IgG and serum neutralizing antibody titers. Our
results suggest that soluble rGST-COE and rGST-S1D
may have potential to be used as efficient subunit vac-
cine antigens for the PEDV prevention. Further studies
will be followed to evaluate the efficacy of those recom-




The expression plasmids, pG-COE and pG-S1D were con-
structed by ligating pGEX-6p-1 (GE Healthcare, Uppsala,
Sweden) with COE (aa 499–636) and S1D (aa 637–789)
regions, respectively, in BamH1 and Xho1 sites. The COE
and S1D fragments based on the nucleotide sequence of
spike protein of PEDV CV777 strain (GenBank Acc. No.
AF353511) were synthesized after codon-optimization by
Genscript (Piscataway, NJ, USA). These expression plas-
mids produced recombinant spike proteins, rGST-COE
and rGST-S1D, as glutathione S-transferase (GST)-tagged
fusion proteins under the tac promoter (Ptac). Each plas-
mid was transformed into E.coli BL21, BL21/pTf16, BL21/
pGro7, BL21/pG-KJE8 and BL21/pG-Tf2 competent cells
(TaKaRa, Japan). E.coli BL21/pTf16 strain produced the
trigger factor (TF) under the L-arabinose inducible pro-
moter. On the other hand, E.coli BL21/pGro7 and
BL21/pG-KJE8 strains produced GroEL-GroES and
DnaK-DnaJ-GrpE/GroEL-GroES chaperone complex,
Fig. 5 Detection of antigen specific serum IgG levels from mice
immunized with rGST-COE (a) and rGST-S1D (b) by ELISA. Mice
(n = 5) were immunized subcutaneously with 10 μg of purified proteins
three times at 2-weeks intervals. Pre-immune sera and sera from two
weeks following each injection were serially diluted and assayed by
ELISA. Error bars indicate the standard deviations of the means
Fig. 6 Reactivity of purified rGST-COE and rGST-S1D with pig anti-PEDV
immune sera in an indirect ELISA. The rGST was included as a negative
control. Error bars indicate the standard deviations of the means.
The asterisk indicates the p values that are less than 0.05
Fig. 7 Serum neutralizing (SN) antibody titers from mice immunized
with PBS, rGST-COE and rGST-S1D. Terminal serum samples were serially
diluted and subjected to the serum neutralization assay. Error bars
indicate the standard deviations of the means. The asterisk indicates
the p values that were less than 0.05
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respectively. E.coli BL21/pG-Tf2 strain produced
GroEL-GroES/TF complex.
Recombinant protein expression
A seed culture was prepared by inoculating with a single
colony of recombinant E.coli strains and grown over-
night in 5 ml of LB broth containing 100 μg/ml of ampi-
cillin in a 50 ml sterile plastic tubes. For the expression
of recombinant proteins, 1 % seed culture was routinely
inoculated to 25 ml of LB broth containing 0.5 mg/ml of
L-arabinose, 100 μg/ml of ampicillin and 20 μg/ml of
chloramphenicol in 100 ml baffled flasks, followed by
adding L-arabinose (0.5 mg/ml) and/or tetracycline
(10 ng/ml) for the induction of chaperone proteins. Cells
were cultured with shaking at 230 rpm and 37 °C. The
growth was monitored by measuring the absorbance of
optical density (OD) at 600 nm with a spectrophotom-
eter. When the OD600 of the culture reaches set point,
cultures were cooled to 4 °C for 30 min and induced by
0.1 mM IPTG at 15 °C for 24 h.
To check the chaperone effect of trigger factor, E.coli
BL21/pTf16/pG-COE and E.coli BL21/pTf16/pG-S1D were
shake-cultured in LB broth at 37 °C until OD600 reached
0.6, cooled to 4 °C for 30 min and induced at 15 °C for
24 h with or without IPTG (0.1 mM) and with or without
L-arabinose (0.5 mg/ml) to detect the protein expression.
Cells were harvested and disrupted on ice by sonication
(VCX 750, SONICS, Newtown, CT, USA) using a program
(45 cycles of 2 sec On/5 s Off, amp 20 %) and centrifuged
at 20,000 g for 15 min at 4 °C. The pellets and super-
natants were separately stored at −20 °C until use.
Protein concentration was measured by Bradford assay
(BioRad, CA, USA) using bovine serum albumin (BSA)
as a standard. Protein expression was evaluated using
band intensities of recombinant protein on sodium
dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) from independent and/or parallel induc-
tion samples.
Optimization of soluble recombinant protein expression
To find the optimal conditions for the soluble expression
of recombinant proteins, the effect of various induction
conditions for E.coli BL21/pTf16/pG-COE and E.coli
BL21/pTf16/pG-S1D strains were optimized by regulat-
ing induction temperature (15 °C for 24 h, 21 °C for
16 h, 28 °C for 8 h and 37 °C for 4 h with 0.1 mM IPTG
when OD600 reaches about 0.6), IPTG concentration
(0.1, 0.4, 0.7 and 1.0 mM at 15 °C for 24 h shake culture
starting at OD600 of 0.6), OD at induction (OD600 =
0.6, 0.9, 1.2 and 1.5 at 15 °C for 24 h shake culture with
0.1 mM IPTG) and harvest time (12, 24, 36 and 48 h
after induction at 15 °C with 0.1 mM IPTG).
Protein purification and analysis
Soluble recombinant proteins were purified from the
crude cell extracts by glutathione-affinity chromatog-
raphy using a glutathione Sepharose 4B (GE Healthcare,
Sweden). The column was equilibrated with 5 column
volume of binding buffer (140 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4 and 1.8 mM KH2PO4, pH 7.3) and
crude soluble proteins were applied. The column was
washed with 5 column volume of binding buffer and
bound proteins were eluted with elution buffer (50 mM
Tris–HCl and 10 mM glutathione, pH 8.0).
Proteins were analyzed by SDS-PAGE on pre-maid 12 %
polyacrylamide mini-gels (KomaBiotech, Korea) run in a
Mini-PROTEAN electrophoresis system (Bio-Rad, CA,
USA). Gels were stained with Coomassie Blue R250 and
images were analyzed by image analysis software of a Che-
miDoc™ MP System (BioRad, CA, USA). For the western
blot assay, proteins after SDS-PAGE run were transferred
to a nitrocellulose membrane (Whatman, USA) in a Mini
Trans-Blot system (BioRad, USA). Then the membrane
was blocked with Tris-buffered saline/0.1 % Tween 20
(TBST) containing 5 % skim milk (BD/Difco, NJ, USA) for
1 h and probed with mouse anti-GST monoclonal anti-
body (Genscript, USA) and pig anti-sera against PEDV in
TBST at 1:1000 and 1:500 dilutions, respectively, for 1 h
both at room temperature. HRP-conjugated goat anti-
mouse IgG (MerckMillipore, Germany) and goat anti-
porcine IgG (KPL, USA) diluted at 1:5000 were used as
secondary antibody. Detection was carried out using an
ECL detection kit (GE Healthcare, Sweden).
Indirect enzyme-linked immunosorbent assay (ELISA)
The reactivity of purified proteins with pig anti-sera
against PEDV was tested by an indirect ELISA. The 96
well Immuno-plate (SPL, South Korea) was coated with
5 μg/ml of purified proteins in carbonate buffer (pH 9.6)
at 4 °C overnight. Plates were blocked with 1 % bovine
serum albumin (BSA) in PBS for 2 h at room temperature.
Pre-immune and immune sera were obtained from pigs
before and after immunization of commercial PEDV vac-
cine (Green Cross, South Korea). Sera diluted at 1:1000
were added to the corresponding wells and incubated for
1 h at room temperature. HRP conjugated goat anti-
porcine IgG (KPL, USA) at 1:2500 dilution was added and
incubated for 1 h at room temperature. Plates were incu-
bated with the TMB substrate solution (Sigma, USA) for
15 min in the dark and reaction was stopped by adding
sulfuric acid. Absorbance at 450 nm was measured in an
Infinite 200 PRO microplate reader (Tekan, Switzerland).
Mouse immunization and detection of antibody production
Six-week-old female BALB/c mice were purchased from
Samtako (Osan, Korea). The experiments were performed
in accordance with the guidelines for the care and use of
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laboratory animals under the approval of animal ethics
committee at Seoul National University (SNU-130415–1).
The mice, maintained under standard pathogen-free con-
ditions, were provided with free access to food and water
during the experiments. Mice (n = 5) were immunized
subcutaneously with 10 μg of purified proteins three times
at 2-week intervals. Complete Freund’s adjuvant (CFA)
and incomplete Freund’s adjuvant (IFA) were mixed with
antigens for the priming and boosting of animals. Sera
were collected from the mice at 0, 14, 28 and 42 days after
first immunization for the antibody detection and serum
neutralization assay.
The induction of antigen specific serum IgG level was
measured by ELISA. Plates were coated and blocked
using the same method described in the indirect ELISA
section. After blocking, 2 fold serial diluted mouse sera
were added to the wells and incubated for 1 h at room
temperature. HRP conjugated goat anti-mouse IgG
secondary antibody diluted at 1:5000 was added and
incubated for 1 h at room temperature. Other assay pro-
cedures are same as described in the indirect ELISA
section.
Serum neutralization (SN) assay
The presence of PEDV specific neutralizing antibodies in
the serum collected from immunized mice was deter-
mined by a serum neutralizing assay. Terminal serum
samples were inactivated at 56 °C for 30 min, followed
by 2 fold serial dilutions in a serum-free α-MEM con-
taining 1 % antibiotic-antimycotic solution (Invitrogen,
USA). PEDV SM98 isolate of 200 TCID50/0.1 ml was
mixed with an equal volume of diluted sera. After incu-
bation for 1 h at 37 °C, 0.1 ml of each virus-serum mix-
ture was inoculated onto Vero cell monolayers in the
96-well tissue culture plates. After adsorption for 1 h at
37 °C, virus-serum mixture was removed and plates were
washed 3 times with PBS. Serum-free α-MEM medium
containing trypsin (2.5 μg/ml) was then added into each
well and incubated for 3 ~ 6 days at 37 °C. The SN titers
were expressed as the highest serum dilution resulting
in the inhibition of cytopathic effect.
Statistical analysis
The Student’s t test was used for all statistical analyses,
and p-values of less than 0.05 were considered statisti-
cally significant.
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